CXC ligand 9 response to malaria during pregnancy is associated with low-birth-weight deliveries

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3034-3038

  Dong, Shu ^a   Kurtis, Jonathan D ^b   Pond Tor, Sunthorn ^b   Kabyemela, Edward ^a   Duffy, Patrick E ^a,c   Fried, Michal ^a,c  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIRTH WEIGHT; BLOOD; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LOW BIRTH WEIGHT; MALARIA; PLACENTA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BLOOD CHEMICAL ANALYSIS; CHEMOKINE CXCL9; COHORT STUDIES; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TANZANIA; YOUNG ADULT;

EID: 84867611172     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00220-12     Document Type: Article

References (28)

1. Abrams ET, et al. 2003. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J. Immunol. 170:2759-2764.
2. Brice GT, Graber NL, Hoffman SL, Doolan DL. 2001. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-γ production and IFN-γ-secreting cells. J. Immunol. Methods 257:55-69.
3. Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. 1993. Placental malaria. I. Pathological classification. Histopathology 22:211-218.
4. Chaisavaneeyakorn S, et al. 2003. Levels of macrophage inflammatory protein 1α (MIP-1α) and MIP-1β in intervillous blood plasma samples from women with placental malaria and human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 10:631-636.
5. Desai M, et al. 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7:93-104.
6. Fried M, Muga RO, Misore AO, Duffy PE. 1998. Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J. Immunol. 160:2523-2530.
7. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. 1998. Maternal antibodies block malaria. Nature 395:851-852.
8. Garnham PCC. 1938. The placenta in malaria with special reference to reticulo-endothelial immunity. Trans. R. Soc. Trop. Med. Hyg. 32:13-48.
9. Jilly P. 1969. Anaemia in parturient women, with special reference to malaria infection of the placenta. Ann. Trop. Med. Parasitol. 63:109-116.
10. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE. 2008. Fetal responses during placental malaria modify the risk of low birth weight. Infect. Immun. 76:1527-1534.
11. Kabyemela ER, et al. 2008. Maternal peripheral blood level of IL-10 as a marker for inflammatory placental malaria. Malar. J. 7:26.
12. Kim MJ, et al. 2009. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J. Immunol. 182:3919-3927.
13. Liao F, et al. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182:1301-1314.
14. McGregor IA. 1984. Epidemiology, malaria and pregnancy. Am. J. Trop. Med. Hyg. 33:517-525.
15. Moore JM, Nahlen BL, Misore A, Lal AA, Udhayakumar V. 1999. Immunity to placental malaria. I. Elevated production of interferongamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J. Infect. Dis. 179:1218-1225.
16. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
17. Moormann AM, et al. 1999. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J. Infect. Dis. 180:1987-1993.
18. Muehlenbachs A, Fried M, Lachowitzer J, Mutabingwa TK, Duffy PE. 2007. Genome-wide expression analysis of placental malaria reveals features of lymphoid neogenesis during chronic infection. J. Immunol. 179:557-565.
19. Muller G, Hopken UE, Lipp M. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195:117-135.
20. Mutabingwa TK, et al. 2005. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med. 2:e407. doi:10.1371/journal.pmed.0020407.
21. Ordi J, et al. 1998. Massive chronic intervillositis of the placenta associated with malaria infection. Am. J. Surg. Pathol. 22:1006-1011.
22. Parekh FK, Davison BB, Gamboa D, Hernandez J, Branch OH. 2010. Placental histopathologic changes associated with subclinical malaria infection and its impact on the fetal environment. Am. J. Trop. Med. Hyg. 83:973-980.
23. Rogerson SJ, et al. 2003. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect. Immun. 71:267-270.
24. Steketee RW, Nahlen BL, Parise ME, Menendez C. 2001. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 64:28-35.
25. Suguitan AL, Jr, et al. 2003. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. Am. J. Trop. Med. Hyg. 69:574-581.
26. Suguitan AL, Jr, et al. 2003. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J. Infect. Dis. 188:1074-1082.
27. Watkinson M, Rushton DI. 1983. Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers. Br. Med. J. (Clin. Res. Ed.) 287:251-254.
28. Whiting D, et al. 2004. Chemokine monokine induced by IFN-γ/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 172:7417-7424.